Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC)

NCT04057365 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
15
Enrollment
OTHER
Sponsor class

Stopped Based on a Simon 2-stage design, this study did not meet response criteria to proceed to stage 2.

Conditions

Interventions

Sponsor

Massachusetts General Hospital

Collaborators